{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "20606485",
  "DateCompleted": {
    "Year": "2011",
    "Month": "02",
    "Day": "18"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "20"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2010",
        "Month": "07",
        "Day": "02"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1159/000317205"
    ],
    "Journal": {
      "ISSN": "1660-2110",
      "JournalIssue": {
        "Volume": "116",
        "Issue": "3",
        "PubDate": {
          "Year": "2010"
        }
      },
      "Title": "Nephron. Clinical practice",
      "ISOAbbreviation": "Nephron Clin Pract"
    },
    "ArticleTitle": "Association of cystatin C and depression in healthy elders: the health, aging and body composition study.",
    "Pagination": {
      "StartPage": "c241",
      "EndPage": "c246",
      "MedlinePgn": "c241-6"
    },
    "Abstract": {
      "AbstractText": [
        "Depression is highly prevalent in individuals with advanced kidney disease, but is less well studied in individuals with milder disease. We evaluated the association between kidney function and depression in the Health, Aging and Body Composition (Health ABC) study.",
        "The study enrolled 3,075 community-dwelling black and white adults aged 70-79 years. Kidney function was measured by cystatin C and estimated glomerular filtration rate (eGFR). The main outcome was incident treated depression.",
        "52% of participants had low (\u22641.0), 33% intermediate (>1-1.25) and 15% high cystatin C (>1.25). Kidney function and depression were not associated at baseline. Of 2,731 nondepressed participants at baseline, 95 developed incident depression during follow-up. In unadjusted Cox proportional hazard models, hazard ratios (HR) for incident depression were 1.89 (95% confidence interval (CI) 1.21-2.97) for the intermediate and 2.17 (CI 1.24-3.79) for the high cystatin C group. Intermediate (HR = 1.84) and high (HR = 2.1) serum cystatin C remained associated with incident depression in adjusted models. Chronic kidney disease, defined by an eGFR <60 ml/min/1.73 m(2), was not associated with depression.",
        "Participants with higher cystatin C had an increased likelihood of developing treated depression. Future studies should target this high-risk group."
      ],
      "CopyrightInformation": "Copyright \u00a9 2010 S. Karger AG, Basel."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Renal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, Pa. 15216 , USA. evgueni.minev@gmail.com"
          }
        ],
        "LastName": "Minev",
        "ForeName": "Evgueni",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Unruh",
        "ForeName": "Mark",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Shlipak",
        "ForeName": "Michael G",
        "Initials": "MG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Simsonick",
        "ForeName": "Eleanor",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Yaffe",
        "ForeName": "Kristine",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Leak",
        "ForeName": "Tennille S",
        "Initials": "TS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Newman",
        "ForeName": "Anne B",
        "Initials": "AB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Fried",
        "ForeName": "Linda F",
        "Initials": "LF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "CollectiveName": "Health ABC Study"
      }
    ],
    "GrantList": [
      {
        "GrantID": "P30 AG024827",
        "Acronym": "AG",
        "Agency": "NIA NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Nephron Clin Pract",
    "NlmUniqueID": "101159763",
    "ISSNLinking": "1660-2110"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Biomarkers"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "CST3 protein, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Cystatin C"
    },
    {
      "RegistryNumber": "AYI8EX34EU",
      "NameOfSubstance": "Creatinine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Aging"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antidepressive Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Biomarkers"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Body Composition"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Chronic Disease"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Creatinine"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Cystatin C"
    },
    {
      "QualifierName": [
        "blood",
        "drug therapy",
        "epidemiology",
        "etiology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "blood",
        "drug therapy",
        "epidemiology",
        "etiology"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Follow-Up Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Glomerular Filtration Rate"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Incidence"
    },
    {
      "QualifierName": [
        "blood",
        "psychology"
      ],
      "DescriptorName": "Kidney Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Proportional Hazards Models"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prospective Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    }
  ]
}